TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TMDX TransMedics Group, Inc.

Closed 12-22 16:00:00 EST

129.35

+1.68

+1.32%

盘后129.35

+0.000.00%

19:47 EST

High133.29	Low128.10	Vol1.53M
Open129.58	D1 Closing127.67	Amplitude4.07%
Mkt Cap4.42B	Tradable Cap4.26B	Total Shares34.17M
T/O199.20M	T/O Rate4.65%	Tradable Shares32.95M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TMDX","market":"US","secType":"STK","nameCN":"TransMedics Group, Inc.","latestPrice":129.35,"timestamp":1766437200000,"preClose":127.67,"halted":0,"volume":1532208,"hourTrading":{"tag":"盘后","latestPrice":129.35,"preClose":129.35,"latestTime":"19:47 EST","volume":809849,"amount":104753827.3004,"timestamp":1766450864140},"delay":0,"floatShares":32954993,"shares":34174325,"eps":2.535994,"marketStatus":"Closed","change":1.68,"latestTime":"12-22 16:00:00 EST","open":129.58,"high":133.29,"low":128.1,"amount":199196922.7416,"amplitude":0.040652,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.535994,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766480400000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1556769600000,"exchange":"NASDAQ","adjPreClose":127.67,"preHourTrading":{"tag":"盘前","latestPrice":130.3,"preClose":127.67,"latestTime":"09:29 EST","volume":8030,"amount":1034972.9687000001,"timestamp":1766413784349},"postHourTrading":{"tag":"盘后","latestPrice":129.35,"preClose":129.35,"latestTime":"19:47 EST","volume":809849,"amount":104753827.3004,"timestamp":1766450864140},"volumeRatio":1.885825,"impliedVol":0.5612,"impliedVolPercentile":0.228},"requestUrl":"/m/hq/s/TMDX","defaultTab":"news","newsList":[{"id":"2592948982","title":"TransMedics Group Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2592948982","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592948982?lang=en_us&edition=fundamental","pubTime":"2025-12-18 04:19","pubTimestamp":1766002740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TMDX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 17, 2025 15:19 ET (20:19 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU2065731478.USD","BK4588","LU2324357040.USD","TMDX","BK4585"],"gpt_icon":0},{"id":"2589358782","title":"Needham Raises Price Target on TransMedics Group to $166 From $148, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2589358782","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589358782?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:56","pubTimestamp":1765198582,"startTime":"0","endTime":"0","summary":"TransMedics Group (TMDX) has an average rating of overweight and mean price target of $145.92, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU2324357040.USD","BK4588","BK4082","LU2065731478.USD","TMDX"],"gpt_icon":0},{"id":"2589330463","title":"TransMedics Group Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2589330463","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589330463?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:23","pubTimestamp":1765196580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TMDX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 08, 2025 07:23 ET (12:23 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4082","TMDX","LU2065731478.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"2589881060","title":"TransMedics Director David Weill Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2589881060","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589881060?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:30","pubTimestamp":1764970249,"startTime":"0","endTime":"0","summary":"David Weill, Director, reported a disposal of common shares of TransMedics Group Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL5fcbdX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"TransMedics Director David Weill Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","BK4585","TMDX","LU2324357040.USD","BK4588","BK4082"],"gpt_icon":0},{"id":"2587754412","title":"Is Now the Right Time for TransMedics After a 120% Surge and FDA Approvals?","url":"https://stock-news.laohu8.com/highlight/detail?id=2587754412","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587754412?lang=en_us&edition=fundamental","pubTime":"2025-11-29 12:18","pubTimestamp":1764389929,"startTime":"0","endTime":"0","summary":"Curious if TransMedics Group is still a bargain or if the huge price moves have put it out of reach? Let’s break down whether now is the right time to buy in or stay on the sidelines.\nTransMedics stock has soared 120.0% year-to-date and 68.7% over the past year, drawing fresh attention from growth investors and those tracking emerging medical technology trends.\nMuch of this renewed interest follows industry headlines about innovations in organ transplant logistics and successful expansion...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/is-now-the-right-time-for-transmedics-after-a-120-surge-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/is-now-the-right-time-for-transmedics-after-a-120-surge-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2324357040.USD","TMDX","DCF","LU2065731478.USD","BK4588","BK4585","BK4082"],"gpt_icon":0},{"id":"2586298372","title":"TransMedics Group Inc. Officer Anil P. Ranganath Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586298372","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586298372?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:31","pubTimestamp":1764192668,"startTime":"0","endTime":"0","summary":"Anil P. Ranganath, an officer of TransMedics Group Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL5xmBhz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"TransMedics Group Inc. Officer Anil P. Ranganath Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","TMDX","LU2324357040.USD","LU2065731478.USD","BK4585","BK4082"],"gpt_icon":0},{"id":"2586405069","title":"3 Companies Including TransMedics Group That May Be Trading Below Estimated Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2586405069","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586405069?lang=en_us&edition=fundamental","pubTime":"2025-11-26 01:08","pubTimestamp":1764090484,"startTime":"0","endTime":"0","summary":"As the U.S. stock market experiences a mixed performance, with major indices like the Dow Jones and S&P 500 mostly rising while technology shares face pressure, investors are keenly observing opportunities amidst fluctuating economic indicators such as retail sales and consumer confidence. In this environment, identifying undervalued stocks can be crucial for those looking to capitalize on potential market inefficiencies, with companies like TransMedics Group offering intriguing possibilities...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-fix/comfort-systems-usa/news/3-companies-including-transmedics-group-that-may-be-trading","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-fix/comfort-systems-usa/news/3-companies-including-transmedics-group-that-may-be-trading","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7095","LU0154245673.USD","BK4613","BK4129","LU0963586101.USD","LU0170899867.USD","LU2065731478.USD","LU1988902786.USD","LU0029874061.USD","BK4141","BK4023","LU0128526141.USD","BK4077","LU1303367103.USD","BK4588","LU2098885051.SGD","BK4146","BK4121","BK4207","WBTN.AU","CROX","SHC","BK4567","FIX","BK4211","LU0054578231.USD","LU0053671581.USD","NIC","LU1923622291.USD","ESTC","TMDX","LU2324357040.USD","LU2125909916.SGD","LU1064131342.USD","BK4608","BK4082","PRSO","BUSE","BK4550","FITB","HBAN","LU0154245756.USD","WBTN","LU2125909759.SGD","LU2264538146.SGD","NIC.AU","FRSH","BK4585"],"gpt_icon":0},{"id":"2586473037","title":"William O'Neil Initiates TransMedics Group at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2586473037","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586473037?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:06","pubTimestamp":1764075993,"startTime":"0","endTime":"0","summary":"TransMedics Group (TMDX) has an average rating of overweight and mean price target of $143.42, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","LU2324357040.USD","BK4585","LU2065731478.USD","BK4588","TMDX"],"gpt_icon":0},{"id":"2585775122","title":"Why TransMedics Group (TMDX) Is Up 13.8% After Analyst Upgrades and Bullish Technical Breakout","url":"https://stock-news.laohu8.com/highlight/detail?id=2585775122","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585775122?lang=en_us&edition=fundamental","pubTime":"2025-11-22 07:33","pubTimestamp":1763768006,"startTime":"0","endTime":"0","summary":"TransMedics Group recently saw a series of upward earnings estimate revisions from analysts, paired with its stock breaking through both the 20-day and 50-day moving averages, technical signals often interpreted as bullish for short-term momentum.\nThis surge in positive analyst sentiment, unmatched by any downward revisions, coincides with technical momentum and signals renewed market confidence in the company’s near-term prospects.\nWe’ll assess how these analyst estimate upgrades and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/why-transmedics-group-tmdx-is-up-138-after-analyst-upgrades","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/why-transmedics-group-tmdx-is-up-138-after-analyst-upgrades","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TMDX"],"gpt_icon":1},{"id":"2584921485","title":"TransMedics rises 10.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584921485","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584921485?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:05","pubTimestamp":1763571915,"startTime":"0","endTime":"0","summary":"TransMedics (TMDX) is up 10.4%, or $12.12 to $129.19. Published first on TheFly – the ultimate source for real-time, market-moving breaking financi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transmedics-rises-10-4-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transmedics-rises-10-4-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMDX","LU2065731478.USD","LU2324357040.USD","BK4082","BK4588","BK4585"],"gpt_icon":0},{"id":"2584966619","title":"TransMedics Group CEO Waleed H. Hassanein Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584966619","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584966619?lang=en_us&edition=fundamental","pubTime":"2025-11-19 05:30","pubTimestamp":1763501440,"startTime":"0","endTime":"0","summary":"Waleed H. Hassanein, President & CEO, reported the acquisition of common shares of TransMedics Group, Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 18, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL5TLwFd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TransMedics Group CEO Waleed H. Hassanein Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU2065731478.USD","BK4588","LU2324357040.USD","TMDX","BK4585"],"gpt_icon":0},{"id":"2584335621","title":"3 Stocks Estimated To Be Trading Below Their Intrinsic Value In November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2584335621","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584335621?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:08","pubTimestamp":1763377680,"startTime":"0","endTime":"0","summary":"In the current climate of mixed market performance, with the Dow Jones Industrial Average experiencing fluctuations and tech stocks facing valuation concerns, investors are keenly observing opportunities for potential undervalued assets. As we explore three stocks estimated to be trading below their intrinsic value in November 2025, understanding what constitutes a good investment becomes crucial—particularly in identifying companies that may offer strong fundamentals and growth potential...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/4121000-choice1-main-header/1585186790255","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4121000-choice1-main-header/1585186790255"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-durables/nyse-onon/on-holding/news/3-stocks-estimated-to-be-trading-below-their-intrinsic-value-14","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-durables/nyse-onon/on-holding/news/3-stocks-estimated-to-be-trading-below-their-intrinsic-value-14","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0069063385.USD","LU2756315664.SGD","IE00BZ9MQY76.HKD","KRMD","BK4561","LU2458330169.SGD","CNH","LU0353189763.USD","LU0648001328.SGD","ONON","LU0943347566.SGD","LU2361045086.USD","WGS","CRM.AU","LU1267930490.SGD","BK4207","LU2210149790.SGD","LU2265009873.SGD","LU0234570918.USD","LU0289961442.SGD","HBAN","LU0251142724.SGD","LU0511384066.AUD","BUSE","WIX","LU0353189680.USD","CCNE","LU1823568750.SGD","LU0251131958.USD","BK4588","LU2361044865.SGD","HUBS","LU2361044949.HKD","BK4196","FITB","LU0345780950.USD","LU2210150020.SGD","LU0289739343.SGD","LU2095319765.USD","LU0719512351.SGD","ONB","BK4023","LU2458330243.SGD","LU0109392836.USD","LU0128526141.USD","TMDX","BK4527","LU0820561818.USD","HCC","CRM"],"gpt_icon":0},{"id":"2583350665","title":"November 2025 Stocks Estimated To Be Trading Below Their Fair Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2583350665","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583350665?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:08","pubTimestamp":1763118489,"startTime":"0","endTime":"0","summary":"In November 2025, the U.S. stock market has experienced significant volatility, with major indices like the Dow Jones and Nasdaq suffering sharp declines due to tumbling tech shares amidst economic uncertainties following a prolonged federal government shutdown. Despite these fluctuations, opportunities may arise for investors seeking undervalued stocks that could be trading below their fair value. Identifying such stocks often involves analyzing companies with strong fundamentals that may...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9612015-choice1-main-header/1585186799831","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9612015-choice1-main-header/1585186799831"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate-management-and-development/nyse-hhh/howard-hughes-holdings/news/november-2025-stocks-estimated-to-be-trading-below-their-fai","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate-management-and-development/nyse-hhh/howard-hughes-holdings/news/november-2025-stocks-estimated-to-be-trading-below-their-fai","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HBAN","BK4548","ASIC","TPR","LU0128525689.USD","BK4107","BK4585","LU0154245673.USD","BK4007","BK4116","WIX","LYFT","BK4550","ONB","BK4104","BK4211","LU0128526141.USD","BK7104","LU1169589451.USD","LU0208291251.USD","LU0029874061.USD","LU1267930227.SGD","BUSE","LU0963586101.USD","BK4187","PAHC","LU0320765489.SGD","FLY","LU0154245756.USD","LU0310800965.SGD","BK4516","BK4202","BK4022","LU0052756011.USD","HHH","CAI.AU","LU1169590202.USD","BK4230","BK4024","CAI","TMDX","BK4139","LU2065731478.USD","LU2324357040.USD","BK4588","BK4121","BK4082","LU0070302665.USD","BLFS","BK4198"],"gpt_icon":0},{"id":"2582751588","title":"TransMedics Group (TMDX) Receives a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2582751588","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582751588?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:19","pubTimestamp":1762777158,"startTime":"0","endTime":"0","summary":"In a report released today,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/transmedics-group-tmdx-receives-a-buy-from-piper-sandler-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/transmedics-group-tmdx-receives-a-buy-from-piper-sandler-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4082","TMDX","LU2065731478.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"2580243116","title":"Oppenheimer Remains a Buy on TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2580243116","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580243116?lang=en_us&edition=fundamental","pubTime":"2025-11-04 00:57","pubTimestamp":1762189038,"startTime":"0","endTime":"0","summary":"Oppenheimer analyst Suraj Kalia maintained a Buy rating on TransMedics Group today and set a price target of $150.00. The company’s shares opened t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-remains-a-buy-on-transmedics-group-tmdx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-remains-a-buy-on-transmedics-group-tmdx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","LU2065731478.USD","OPY","TMDX","LU2324357040.USD","BK4082","BK4588","BK4585"],"gpt_icon":0},{"id":"2580941699","title":"TransMedics Director Edward M. Basile Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2580941699","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580941699?lang=en_us&edition=fundamental","pubTime":"2025-11-01 04:30","pubTimestamp":1761942645,"startTime":"0","endTime":"0","summary":"Edward M. Basile, Director of TransMedics Group Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 31, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nNDL14cDmd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","TMDX","LU2324357040.USD","BK4585","BK4082","LU2065731478.USD"],"gpt_icon":0},{"id":"2580415499","title":"TransMedics Grants Stock Options and RSUs to New Employees as Hiring Incentive","url":"https://stock-news.laohu8.com/highlight/detail?id=2580415499","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580415499?lang=en_us&edition=fundamental","pubTime":"2025-11-01 04:05","pubTimestamp":1761941129,"startTime":"0","endTime":"0","summary":"TransMedics Group Inc. has announced new compensation terms for 15 recently hired employees, granting a total of 27,582 non-qualified stock options and 18,299 restricted stock units. The stock options have an exercise price of $132.45 per share and will vest 25% on the first anniversary of employment, with the remaining shares vesting monthly over the following three years. The restricted stock units will vest 25% on each of the first four anniversaries of the employee's start date. Both the stock options and restricted stock units are subject to the terms of the company's Inducement Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via PR Newswir","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nNDL708yKt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LU2065731478.USD","BK4082","TMDX","LU2324357040.USD"],"gpt_icon":0},{"id":"2579178654","title":"BUZZ-U.S. STOCKS ON THE MOVE-Fiserv, CMS Energy, Moderna","url":"https://stock-news.laohu8.com/highlight/detail?id=2579178654","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579178654?lang=en_us&edition=fundamental","pubTime":"2025-10-31 01:41","pubTimestamp":1761846118,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Fiserv, CMS Energy, ModernaEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nL6N3WB0L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","FI","HSY","IP","NAVN","CMS","CVNA","SIRI","MNMD","SFM","WOLF","BIIB","BMY","CMG","CHRW","LHX","PWR","VERU","DOCU","EBAY","MO","KMB","HWM","SVRA","FISV","EXR","INTS","AME","EL","RIOT","MRNA","CAH","CMCSA","SHAK","MGM","LKQ","SNSE","TMDX","CLF","FOXA"],"gpt_icon":1},{"id":"2579123103","title":"TransMedics Group Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2579123103","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579123103?lang=en_us&edition=fundamental","pubTime":"2025-10-30 22:17","pubTimestamp":1761833820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TMDX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 30, 2025 10:17 ET (14:17 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","BK4082","LU2324357040.USD","TMDX","BK4585","BK4588"],"gpt_icon":0},{"id":"2579128691","title":"TransMedics Group Is Maintained at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2579128691","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579128691?lang=en_us&edition=fundamental","pubTime":"2025-10-30 21:52","pubTimestamp":1761832320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TMDX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 30, 2025 09:52 ET (13:52 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2324357040.USD","BK4588","BK4082","LU2065731478.USD","TMDX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transmedics.com","stockEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":-0.0435},{"period":"3month","weight":0.044},{"period":"6month","weight":0.0333},{"period":"1year","weight":1.1092},{"period":"ytd","weight":1.0476}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.014205},{"month":2,"riseRate":0.666667,"avgChangeRate":0.165146},{"month":3,"riseRate":0.333333,"avgChangeRate":0.01893},{"month":4,"riseRate":0.666667,"avgChangeRate":0.108774},{"month":5,"riseRate":0.5,"avgChangeRate":0.127373},{"month":6,"riseRate":1,"avgChangeRate":0.158462},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.012617},{"month":8,"riseRate":0.571429,"avgChangeRate":0.040414},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.096617},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.144574},{"month":11,"riseRate":0.857143,"avgChangeRate":0.223183},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.020908}],"exchange":"NASDAQ","name":"TransMedics Group, Inc.","nameEN":"TransMedics Group, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TransMedics Group, Inc.(TMDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TransMedics Group, Inc.,TMDX,TransMedics Group, Inc.股票,TransMedics Group, Inc.股票老虎,TransMedics Group, Inc.股票老虎国际,TransMedics Group, Inc.行情,TransMedics Group, Inc.股票行情,TransMedics Group, Inc.股价,TransMedics Group, Inc.股市,TransMedics Group, Inc.股票价格,TransMedics Group, Inc.股票交易,TransMedics Group, Inc.股票购买,TransMedics Group, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TransMedics Group, Inc.(TMDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}